Kaldvik AS has initiated a waiver process with its lenders regarding the financial covenants in its senior bank debt facility of EUR 179.9 million. This process has now been successfully concluded.

Castle Biosciences faces significant operational and financial constraints due to the covenants associated with its 2024 Loan and Security Agreement. The agreement, which includes both affirmative ...